Copyright Reports & Markets. All rights reserved.

Global Large Volume Wearable Injectors Market Growth 2019-2024

Buy now

Table of Contents

    2019-2024 Global Large Volume Wearable Injectors Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Large Volume Wearable Injectors Consumption 2014-2024
        • 2.1.2 Large Volume Wearable Injectors Consumption CAGR by Region
      • 2.2 Large Volume Wearable Injectors Segment by Type
        • 2.2.1 Electronical Injectors
        • 2.2.2 Mechanical Injectors
        • 2.2.3 Others
      • 2.3 Large Volume Wearable Injectors Consumption by Type
        • 2.3.1 Global Large Volume Wearable Injectors Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Large Volume Wearable Injectors Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Large Volume Wearable Injectors Sale Price by Type (2014-2019)
      • 2.4 Large Volume Wearable Injectors Segment by Application
        • 2.4.1 Cancer Treatment
        • 2.4.2 Auto-immune Treatment
        • 2.4.3 Blood Disorders Treatment
        • 2.4.4 Others
      • 2.5 Large Volume Wearable Injectors Consumption by Application
        • 2.5.1 Global Large Volume Wearable Injectors Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Large Volume Wearable Injectors Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Large Volume Wearable Injectors Sale Price by Application (2014-2019)

      3 Global Large Volume Wearable Injectors by Players

      • 3.1 Global Large Volume Wearable Injectors Sales Market Share by Players
        • 3.1.1 Global Large Volume Wearable Injectors Sales by Players (2017-2019)
        • 3.1.2 Global Large Volume Wearable Injectors Sales Market Share by Players (2017-2019)
      • 3.2 Global Large Volume Wearable Injectors Revenue Market Share by Players
        • 3.2.1 Global Large Volume Wearable Injectors Revenue by Players (2017-2019)
        • 3.2.2 Global Large Volume Wearable Injectors Revenue Market Share by Players (2017-2019)
      • 3.3 Global Large Volume Wearable Injectors Sale Price by Players
      • 3.4 Global Large Volume Wearable Injectors Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Large Volume Wearable Injectors Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Large Volume Wearable Injectors Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Large Volume Wearable Injectors by Regions

      • 4.1 Large Volume Wearable Injectors by Regions
        • 4.1.1 Global Large Volume Wearable Injectors Consumption by Regions
        • 4.1.2 Global Large Volume Wearable Injectors Value by Regions
      • 4.2 Americas Large Volume Wearable Injectors Consumption Growth
      • 4.3 APAC Large Volume Wearable Injectors Consumption Growth
      • 4.4 Europe Large Volume Wearable Injectors Consumption Growth
      • 4.5 Middle East & Africa Large Volume Wearable Injectors Consumption Growth

      5 Americas

      • 5.1 Americas Large Volume Wearable Injectors Consumption by Countries
        • 5.1.1 Americas Large Volume Wearable Injectors Consumption by Countries (2014-2019)
        • 5.1.2 Americas Large Volume Wearable Injectors Value by Countries (2014-2019)
      • 5.2 Americas Large Volume Wearable Injectors Consumption by Type
      • 5.3 Americas Large Volume Wearable Injectors Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Large Volume Wearable Injectors Consumption by Countries
        • 6.1.1 APAC Large Volume Wearable Injectors Consumption by Countries (2014-2019)
        • 6.1.2 APAC Large Volume Wearable Injectors Value by Countries (2014-2019)
      • 6.2 APAC Large Volume Wearable Injectors Consumption by Type
      • 6.3 APAC Large Volume Wearable Injectors Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Large Volume Wearable Injectors by Countries
        • 7.1.1 Europe Large Volume Wearable Injectors Consumption by Countries (2014-2019)
        • 7.1.2 Europe Large Volume Wearable Injectors Value by Countries (2014-2019)
      • 7.2 Europe Large Volume Wearable Injectors Consumption by Type
      • 7.3 Europe Large Volume Wearable Injectors Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Large Volume Wearable Injectors by Countries
        • 8.1.1 Middle East & Africa Large Volume Wearable Injectors Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Large Volume Wearable Injectors Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Large Volume Wearable Injectors Consumption by Type
      • 8.3 Middle East & Africa Large Volume Wearable Injectors Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Large Volume Wearable Injectors Distributors
      • 10.3 Large Volume Wearable Injectors Customer

      11 Global Large Volume Wearable Injectors Market Forecast

      • 11.1 Global Large Volume Wearable Injectors Consumption Forecast (2019-2024)
      • 11.2 Global Large Volume Wearable Injectors Forecast by Regions
        • 11.2.1 Global Large Volume Wearable Injectors Forecast by Regions (2019-2024)
        • 11.2.2 Global Large Volume Wearable Injectors Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Large Volume Wearable Injectors Forecast by Type
      • 11.8 Global Large Volume Wearable Injectors Forecast by Application

      12 Key Players Analysis

      • 12.1 West
        • 12.1.1 Company Details
        • 12.1.2 Large Volume Wearable Injectors Product Offered
        • 12.1.3 West Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 West News
      • 12.2 Unilife
        • 12.2.1 Company Details
        • 12.2.2 Large Volume Wearable Injectors Product Offered
        • 12.2.3 Unilife Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Unilife News
      • 12.3 CeQur
        • 12.3.1 Company Details
        • 12.3.2 Large Volume Wearable Injectors Product Offered
        • 12.3.3 CeQur Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 CeQur News
      • 12.4 Sensile Medical
        • 12.4.1 Company Details
        • 12.4.2 Large Volume Wearable Injectors Product Offered
        • 12.4.3 Sensile Medical Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Sensile Medical News
      • 12.5 BD Medical
        • 12.5.1 Company Details
        • 12.5.2 Large Volume Wearable Injectors Product Offered
        • 12.5.3 BD Medical Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 BD Medical News
      • 12.6 Enable Injections
        • 12.6.1 Company Details
        • 12.6.2 Large Volume Wearable Injectors Product Offered
        • 12.6.3 Enable Injections Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Enable Injections News
      • 12.7 Roche
        • 12.7.1 Company Details
        • 12.7.2 Large Volume Wearable Injectors Product Offered
        • 12.7.3 Roche Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Roche News
      • 12.8 ScPharmaceuticals
        • 12.8.1 Company Details
        • 12.8.2 Large Volume Wearable Injectors Product Offered
        • 12.8.3 ScPharmaceuticals Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 ScPharmaceuticals News
      • 12.9 SteadyMed
        • 12.9.1 Company Details
        • 12.9.2 Large Volume Wearable Injectors Product Offered
        • 12.9.3 SteadyMed Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 SteadyMed News
      • 12.10 J & J
        • 12.10.1 Company Details
        • 12.10.2 Large Volume Wearable Injectors Product Offered
        • 12.10.3 J & J Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 J & J News

      13 Research Findings and Conclusion

      Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
      In the coming years there is an increasing demand for Large Volume Wearable Injectors in the regions of US and Europe that is expected to drive the market for more advanced Large Volume Wearable Injectors. Increasing of the cancer, auto-immune, blood disorders and stable rise in aging population will drive growth in United States and Europe markets.
      Globally, the Large Volume Wearable Injectors industry market is concentrated as the manufacturing technology of Large Volume Wearable Injectors is relatively matures than some high-tech equipment. And some enterprises, like West, Unilife, CeQur, etc. are well-known for the wonderful performance of their Large Volume Wearable Injectors and related services. At the same time, United States, occupied 64.61% production market share in 2015, is remarkable in the global Large Volume Wearable Injectors industry because of their market share and technology status of Large Volume Wearable Injectors.
      The consumption volume of Large Volume Wearable Injectors is related to downstream industries and global economy. As there will always be some uncertain in the global economy in the following years, the growth rate of Large Volume Wearable Injectors industry may not keep that fast. But it is surely forecasted that the market of Large Volume Wearable Injectors is still promising.

      According to this study, over the next five years the Large Volume Wearable Injectors market will register a 140.4% CAGR in terms of revenue, the global market size will reach US$ 6680 million by 2024, from US$ 35 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Large Volume Wearable Injectors business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Large Volume Wearable Injectors market by product type, application, key manufacturers and key regions and countries.

      This study considers the Large Volume Wearable Injectors value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Electronical Injectors
      Mechanical Injectors
      Others
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Cancer Treatment
      Auto-immune Treatment
      Blood Disorders Treatment
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      West
      Unilife
      CeQur
      Sensile Medical
      BD Medical
      Enable Injections
      Roche
      ScPharmaceuticals
      SteadyMed
      J & J

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Large Volume Wearable Injectors consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Large Volume Wearable Injectors market by identifying its various subsegments.
      Focuses on the key global Large Volume Wearable Injectors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Large Volume Wearable Injectors with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Large Volume Wearable Injectors submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now